← Back to Search

Behavioral Intervention

Mobile Health Smoking Cessation for Quitting Smoking (PROMOTE-UP Trial)

N/A

Recruiting

Led By Jesse Dallery, PhD

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥21 years old

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up months 6 and 12

Awards & highlights

PROMOTE-UP Trial Summary

This trial tests 3 methods to help smokers quit: a mobile app, a mobile app + support, and a quit line.

Who is the study for?

This trial is for individuals over 21 who smoke and want to quit. They must have daily access to a smartphone, be referred by their primary care provider, and receive care at a participating clinic. People with unstable medical or psychiatric conditions cannot join.Check my eligibility

What is being tested?

The study compares three smoking cessation methods: the iCanQuit mobile app, iCanQuit combined with another app called Motiv8, and the Florida quit line service. It aims to find out which is most effective in helping underserved patients stop smoking.See study design

What are the potential side effects?

Since this trial involves behavioral interventions like apps and counseling services rather than medications, there are no direct side effects as you would expect from drugs; however, participants may experience stress or frustration during the quitting process.

PROMOTE-UP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 years old or older.

PROMOTE-UP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ months 6 and 12

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~months 6 and 12

This trial's timeline: 3 weeks for screening, Varies for treatment, and months 6 and 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Acceptance

Motivation

Quality of Life and Well-Being

+5 more

PROMOTE-UP Trial Design

3Treatment groups

Active Control

Group I: iCanQuit+Motiv8Active Control1 Intervention

Motiv8 is an internet-and smart phone-based contingency management (CM) intervention. Motiv8 verifies smoking status via a hand-held breath carbon monoxide (CO) monitor that is connected to a smart phone. For patients randomized to the iCanQuit+Motiv8 arm (444 total), research staff will assist in downloading the combined pp and connecting the iCO to the patient's phone. Smokers will also be asked to complete the first 4 iCanQuit modules, which contain exercises designed to prepare the users for their quit day. The end of the preparation phase will also mark each patient's quit date. During the intervention (7 weeks), participants will be considered abstinent from smoking if their breath CO sample is ≤ 5 ppm or if the CO value has decreased by 5% per hour from the last sample provided.

Group II: Florida quit lineActive Control1 Intervention

The Florida quit line provides telephone counseling for smoking cessation. Patients randomized to the Florida quit line arm (444 total) will be enrolled after contact information is sent electronically.

Group III: iCanQuitActive Control1 Intervention

iCanQuit is a modern, cognitive behavioral treatment which promotes cessation through greater acceptance of triggers for smoking and commitment to personal values. It is a smart phone-based acceptance and commitment therapy (ACT). For patients randomized to the iCanQuit arm (444 total), research staff will assist in downloading the app onto the patient's phone.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,341 Previous Clinical Trials

714,314 Total Patients Enrolled

Patient-Centered Outcomes Research InstituteOTHER

551 Previous Clinical Trials

29,996,126 Total Patients Enrolled

Jesse Dallery, PhDPrincipal InvestigatorUniversity of Florida

2 Previous Clinical Trials

136 Total Patients Enrolled

Media Library

Florida quit line (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05415761 — N/A

Quitting Smoking Research Study Groups: iCanQuit+Motiv8, Florida quit line, iCanQuit

Quitting Smoking Clinical Trial 2023: Florida quit line Highlights & Side Effects. Trial Name: NCT05415761 — N/A

Florida quit line (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05415761 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are eligible for participation in this experiment?

"Affirmative. According to clinicaltrials.gov, this specific research project is still looking for participants. It was first published on May 15th 2023 and the last update occurred June 7th of that same year. This trial requires 1332 patients across 1 centre."

Answered by AI

Are researchers currently enrolling participants in this experiment?

"Indeed, the details listed on clinicaltrials.gov verify that this medical trial is currently recruiting patients. The original posting date for this study was May 15th 2023 and it has been amended most recently on June 7th 2023. A total of 1332 participants need to be sourced from one single location."

Answered by AI

Who else is applying?

What site did they apply to?

University of Florida

What portion of applicants met pre-screening criteria?

Did not meet criteria

Why did patients apply to this trial?

Tried multiple times to quit myself and really need to quit I want to be healthy and it's taking a toll on me money and health wise. I even tried signing up myself and never got product to help.

PatientReceived no prior treatments

Recent research and studies

clinicaltrials.govStudy

Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care

2023. "Comparative Effectiveness of Mobile Health Smoking Cessation Approaches Among Underserved Patients in Primary Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05415761.

All > Smoking Cessation